PDM08

Prodimed S.A. · Phase 1 active Small molecule

At a glance

Generic name	PDM08
Also known as	4-amino-5-oxo-4(pyridinium-1-ylmethyl)proline D-cis, 3S,5R-1-(3-Amino-5-carboxy-2-oxopyrrolidin-3-ylmethyl)pyridinium bromide hidrobromide
Sponsor	Prodimed S.A.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

PDM08 Clinical Trial in Advanced Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PDM08 CI brief — competitive landscape report
PDM08 updates RSS · CI watch RSS
Prodimed S.A. portfolio CI